Staar Surgical (STAA) Stock: Buy, Sell, or Hold?

STAA - Staar Surgical Co

OPHTHALMIC GOODS
$22.36
-0.02 (-0.09%) â–ŧ
5d: +9.02%
30d: -3.25%
90d: -18.22%
WAIT
LOW Confidence
Protect Your STAA Gains
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026

Get Alerted When STAA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: STAA is fairly priced but lacks strong directional signals. At -16.4% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$50.57
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$31.40
28.8% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: STAA is currently trading at $22.36, which is considered fair relative to its 30-day fair value range of $20.93 to $23.57. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.5) compared to its historical average (36.8). Remarkably, the market is currently pricing in an annual earnings decline of 16.4% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, STAA is in a strong downtrend. The price is approaching resistance at $22.97. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.70 (+23.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $20.93 - $23.57
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 72.4%

Protect Your Profits

Holding STAA? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (59/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 23.8% below Wall St target ($27.70)
  • WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $20.93 - $23.57
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $19.05
Resistance Level $22.97
Current Trend Strong Downtrend
Technical data as of Oct 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 21.54
Wall Street Target $27.70 (+23.8%)
Revenue Growth (YoY) 111.0%
Earnings Growth (YoY) -10.5%
Profit Margin 1.1%
Valuation Discount vs History -16.4% cheaper
PE vs Historical 21.5 vs 36.8 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -16.4% (market-implied from PE analysis)
1-Year Target $20.14 (-10%)
2-Year Target $18.13 (-19%)
3-Year Target $16.32 (-27%)
3-Yr Target (if PE normalizes) (PE: 22→37) $27.87 (+25%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 21.5, Growth: 36.2%) $56.59 (+153%)
Base: (SPY PE: 20.4, Growth: 36.2%) $53.58 (+139%)
Bear: (PE: 17.3, Growth: 36.2%) $45.55 (+104%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (127x PE), but valuation improves significantly next year (22x PE) as earnings recover.
Forward PE: 126.58 | Forward EPS (Implied): $0.18
Bull Case $27.02 (+21%)
Analyst growth 15.0%, PE expands to 132.9
Base Case $22.38 (0%)
Market implied 0.0%, PE stable at 126.6
Bear Case $17.12 (-24%)
Severe decline -15.0%, PE contracts to 113.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.5 to 36.8
Stabilization Target: $38.23 (+70.8%)
PE Expansion Potential: +70.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 02, 2026 10:40 AM ET
Data refreshes hourly during market hours. Next update: 11:40 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for STAA.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALC
Alcon AG
STRONG BUY
27 analysts
$84 50 HOLD
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$476 33 SELL
RMD
ResMed Inc
BUY
19 analysts
$250 62 BUY
COO
The Cooper Companies, Inc
BUY
19 analysts
$66 58 HOLD
WST
West Pharmaceutical Servâ€Ļ
STRONG BUY
13 analysts
$408 52 HOLD

Advanced STAA Option Strategies

Professional options setups generated by AI based on today's STAA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for STAA

STAA Technical Chart STAA Price Prediction STAA Earnings Date STAA Investment Advisor STAA Fair Price Analyzer STAA Options Advisor STAA Options Chain STAA Options Analysis STAA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals